Establishment Labs
About Establishment Labs
Establishment Labs is a global, privately held, medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio.YEAR FOUNDED:
2004
LEADERSHIP:
Founder and CEO: Juan José Chacón-Quirós
COO: Salvador Dada
CFO: Renee Gaeta
JOBS:
Please click here for Establishment Labs job opportunities.
PRODUCTS:
All Products
68 articles about Establishment Labs
-
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
2/14/2024
Establishment Labs Holdings Inc. plans to announce its financial results for the quarter ended December 31, 2023, after the market closes on Wednesday, February 28, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.
-
Establishment Labs Announces Commercial Launch of Motiva Implants in China
1/22/2024
Establishment Labs Holdings Inc. today announced it has launched Motiva ® Implants in China.
-
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
1/9/2024
Establishment Labs Holdings Inc. today announced it has entered into a securities purchase agreement with select institutional accredited investors to purchase common shares of the Company, or pre-funded warrants in lieu thereof.
-
Establishment Labs Announces Participation in Two Upcoming Investment Conferences - November 10, 2023
11/10/2023
Establishment Labs Holdings Inc. today announced its participation in two upcoming investment conferences.
-
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
11/9/2023
Establishment Labs Holdings Inc. today announced it has received National Medical Products Administration (NMPA) approval in China for Motiva ® Implants.
-
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
10/25/2023
Establishment Labs Holdings Inc. plans to announce its financial results for the quarter ended Semptember 30, 2023, after the market closes on Tuesday, November 7, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
-
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
10/16/2023
Establishment Labs Holdings Inc. announced that the U.S. Food and Drug Administration has granted 510 clearance for the Motiva Flora® SmoothSilk® Tissue Expander.
-
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
7/26/2023
Establishment Labs Holdings Inc. plans to announce its financial results for the quarter ended June 30, 2023, after the market closes on Tuesday, August 8, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
-
Establishment Labs to Participate in Two Upcoming Investor Conferences
5/31/2023
Establishment Labs Holdings Inc. today announced its participation in two upcoming investor conferences.
-
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
5/30/2023
Establishment Labs Holdings Inc. today announced it has received CE marking under the European Medical Device Regulation for the Motiva Injector ® , the Motiva ® Inflatable Balloon, and the Motiva ® Channel Dissector.
-
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
4/26/2023
Establishment Labs Holdings Inc. plans to announce its financial results for the quarter ended March 31, 2023 after the market closes on Monday, May 8, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
-
Establishment Labs Surpasses Three Million Motiva Devices
3/29/2023
Establishment Labs Holdings Inc. announced that it has surpassed three million Motiva ® devices in market.
-
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
3/23/2023
Establishment Labs Holdings Inc. today announced it has entered into agreements with four partners in Europe and a second partner chain in Japan for Mia Femtech™ (“Mia®”).
-
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
1/9/2023
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited revenue for the three months and fiscal year ended December 31, 2022.
-
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™
1/3/2023
Establishment Labs Holdings Inc. today announced it has entered into an agreement with Seishin Plastic and Aesthetic Surgery Clinic in Japan for Mia Femtech™ (“Mia ® ”).
-
Establishment Labs Reports Third Quarter 2022 Financial Results
11/7/2022
Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced its financial results for the third quarter ended September 30, 2022.
-
Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022
9/20/2022
Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that it will host an investor event on October 5, 2022 to discuss Mia Femtech®.
-
Establishment Labs Announces Complete Enrollment in Motiva US IDE Study
8/3/2022
Establishment Labs Holdings Inc. today announced it has completed enrollment in the Motiva US IDE clinical study.
-
Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8
7/25/2022
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2022 after the market closes on Monday, August 8, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
-
Establishment Labs Releases 2021 Sustainability Review
7/19/2022
Establishment Labs Holdings Inc. today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.